Articles From: SNC-Lavalin announces its results for the third quarter and nine-month period ended September 30, 2013 to OvaScience Featured at RESOLVE New England Annual Fertility Conference


2013/11/1
SNC-Lavalin announces its results for the third quarter and nine-month period ended September 30, 2013 Canada NewsWire Highlights Revenues for the third quarter of 2013 totalled $1.9 billion , in line with the third quarter of 2012.
Sign-up for SNC-Lavalin announces its results for the third quarter and nine-month period ended September 30, 2013 investment picks
2013/11/1
NEW YORK (MarketWatch) -- Chevron Corp.
Sign-up for Chevron third-quarter profit down on lower margins investment picks
TAMPA, Fla., Nov.
Sign-up for Odyssey Marine Responds to Meson Capital "Short & Distort" Piece investment picks
2013/11/1
SAN JOSE, Calif.
Sign-up for Oclaro Closes Sale of its Amplifier and Micro-Optics Business to II-VI Incorporated investment picks
ARIAD Pharmaceuticals, Inc .
Sign-up for ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits investment picks
IIROC Trading Halt - CLR Canada NewsWire TORONTO , Nov.
Sign-up for IIROC Trading Halt - CLR investment picks
2013/11/1
Oaktree Capital Group, LLC (NYSE: OAK) today reported its unaudited financial results for the quarter ended September 30, 2013.
Sign-up for Oaktree Announces Third Quarter 2013 Financial Results investment picks
2013/11/1
HomeStreet Bank and its parent company, HomeStreet, Inc. (NASDAQ:HMST) (the “Company”), today announced the completion of its acquisition of Fortune Bank (“Fortune”) and YNB Financial Services Corp.
Sign-up for HomeStreet Completes Acquisition of Fortune Bank and Yakima National Bank investment picks
2013/11/1
Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced positive results of a Phase 1b clinical study with Z944, a novel oral T-type calcium channel modulator in development for the treatment of pain.
Sign-up for Zalicus Announces Positive Results of Z944 Phase 1b Clinical Study in Pain investment picks
2013/11/1
Pebblebrook Hotel Trust (the “Company”) (NYSE: PEB) announced today the pricing of its public follow-on offering of 2,200,000 of its common shares of beneficial interest, $0.01 par value per share for expected approximate gross proceeds of $65,340,000 before expenses.
Sign-up for Pebblebrook Hotel Trust Announces Pricing of Public Offering of 2,200,000 Common Shares investment picks
2013/11/1
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “About,” then “Investor Relations,” and then “Events and Webcasts,” and the presentations will be archived there for future reference.
Sign-up for DexCom Announces Upcoming Conference Presentations investment picks
Exelis ( NYSE: XLS ) has been awarded a multi-year contract from The Boeing Company to produce advanced composite vacuum waste tank systems for use on a variety of Boeing commercial aircraft models.
Sign-up for Exelis awarded contract from Boeing for composite tank systems investment picks
PNM Resources (NYSE: PNM): PNM Resources (In millions except EPS) PNM Resources (NYSE: PNM) today released the company’s unaudited 2013 third quarter earnings report.
Sign-up for PNM Resources Reports Third Quarter Results investment picks
2013/11/1
LONDON , GREENWICH, Conn.
Sign-up for Almacantar Secures £220 Million Loan From Starwood Property Trust and Starwood European Real Estate Finance for Centre Point Tower investment picks
2013/11/1
HERNDON, Va., Nov.
Sign-up for ePlus Announces Second Quarter FY 2014 Earnings Release Date and Conference Call investment picks
2013/11/1
Chevron Corporation (NYSE: CVX) today reported earnings of $5.0 billion ($2.57 per share – diluted) for the third quarter 2013, compared with $5.3 billion ($2.69 per share – diluted) in the 2012 third quarter.
Sign-up for Chevron Reports Third Quarter Net Income of $5.0 Billion investment picks
2013/11/1
Héroux-Devtek will hold a conference call to discuss its second quarter results ended September 30, 2013 Canada NewsWire THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL, THROUGH CNW.
Sign-up for Héroux-Devtek will hold a conference call to discuss its second quarter results ended September 30, 2013 investment picks
2013/11/1
Columbia Business School and Morgan Stanley today launched the Morgan Stanley Sustainable Investing Fellowship to develop the next generation of leaders in sustainable investing.
Sign-up for Columbia Business School and Morgan Stanley Launch Sustainable Investing Fellowship investment picks
ALLETE, Inc. (NYSE:ALE) today reported third quarter 2013 earnings of 63 cents per share on net income of $25.2 million and revenue of $251 million, compared to earnings of 78 cents, net income of $29.4 million and revenue of $248.8 million in the third quarter a year ago.
Sign-up for ALLETE Reports Third Quarter Earnings of 63 Cents Per Share investment picks
2013/11/1
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products in orthopedic, sports medicine and wound care markets announced today its financial results for the third quarter of 2013.
Sign-up for Osiris Reports 3rd Quarter 2013 Results: Revenue Up 220%, Strong Balance Sheet, Profitable and Now Cash Flow Positive from Continuing Operations investment picks
Crown Media Holdings, Inc. (NASDAQ:CRWN) today reported its operating results for the three and nine months ended September 30, 2013.
Sign-up for Crown Media Holdings Announces Operating Results for Third Quarter of 2013 investment picks
2013/11/1
-- 2013 third quarter cash dividend of 75 cents per share, bringing 2013 cumulative cash dividends to $14.25 per share SUGAR LAND, Texas , Nov.
Sign-up for CVR Energy Reports 2013 Third Quarter Results And Announces Cash Dividend of 75 Cents investment picks
SUGAR LAND, Texas , Nov.
Sign-up for CVR Refining Reports 2013 Third Quarter Results And Announces Cash Distribution of 30 Cents investment picks
2013/11/1
RALEIGH, N.C., Nov.
Sign-up for Stock Building Supply to Present at Robert W. Baird 2013 Industrial Conference investment picks
Conference Call and Webcast Scheduled for Thursday, November 7 at 11:00 a.m. Eastern Time/8:00 a.m. Pacific Time PASADENA, Calif., Nov.
Sign-up for Western Asset Mortgage Capital Corporation To Report Third Quarter 2013 Financial Results investment picks
OvaScience SM , (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience will present at RESOLVE New England’s 20 th Annual Fertility Conference on November 2, 2013 in Marlborough, MA.
Sign-up for OvaScience Featured at RESOLVE New England Annual Fertility Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: SNC-Lavalin announces its results for the third quarter and nine-month period ended September 30, 2013 to OvaScience Featured at RESOLVE New England Annual Fertility Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity